Here is the counter-intuitive Hormuz name: a defense prime central to missile defense that trades near its 52-week lows in the middle of a Gulf war. Northrop Grumman (NYSE: NOC) is the structural, unglamorous version of the defense trade — and its weakness is the point.
By Ruslan Averin.
The setup
| Metric | Value (Jul 17, 2026) |
|---|---|
| Share price | ~$528 (near 52-wk low) |
| Market cap | ~$75.0B |
| Dividend / yield | ~$9.88 / ~1.9% |
| Backlog | $95.6B |
| P/E (trailing / forward) | ~23 / ~23 |
| FY26 EPS guide | $27.40–27.90 |
Why it works — over years, not weeks
Gulf tension is an interceptor-consumption event, and Northrop sits at the center of the response: IBCS (the battle-command network that ties air-defense sensors and shooters together and cuts interceptors per engagement), munitions, and a leading role in the "Golden Dome" homeland missile-defense program. In the 2026 crisis the US Army fired 24 Patriot interceptors from Al Udeid in Qatar in June alone, and more than $8.6B of new US arms sales to Gulf allies have been flagged, including a ~$2.5B IBCS package for Kuwait.
The honest twist
Despite all that, NOC is near its lows. The June 18 US-Iran interim accord repriced the war premium away, defense primes sold off, and a Q1 Space Systems charge plus B-21 capex worries piled on. So the Hormuz thesis here is not a spot pop — that already faded — it's a long-cycle backlog story ($95.6B) that pays off over years. The live risk is more de-escalation compressing the multiple, and a Q2 print on July 21 that, if merely reaffirmed, could disappoint again.
Bottom line
Northrop is the cheap, structural Hormuz play — the missile-defense prime that replenishes and integrates the shield, now near 52-week lows because June's peace deflated the war premium. That's the contrarian entry, but it's a backlog-and-patience story, not a momentum trade. I do not hold the shares and am not telling anyone to buy or sell — this is analysis, not advice.